Who owns FOGHORN THERAPEUTICS INC?
- Ticker: FHTX
- CUSIP Number: 344174107
Tip: Access positions for across all investors
Analyze quarterly positions in Foghorn Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Foghorn Therapeutics stock
Who bought or sold FOGHORN THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Flagship Ventures Management | 13M | $82M | 0% | Dec 2023 |
|
Raymond James & Associates | 2.1M | $13M | 45% | Dec 2023 |
|
Euclidean Capital | 1.6M | $10M | 0% | Dec 2023 |
|
Vanguard Group | 1.0M | $6.6M | 1% | Dec 2023 |
|
Artal Group | 721k | $4.6M | -58% | Dec 2023 |
|
Point72 Asset Management | 540k | $3.5M | 90% | Dec 2023 |
|
Alphabet | 501k | $3.2M | 0% | Dec 2023 |
|
Rockwood Wealth Management | 215k | $1.4M | 0% | Dec 2023 |
|
Jacobs Levy Equity Management | 108k | $694k | 120% | Dec 2023 |
|
PanAgora Asset Management | 97k | $626k | 181% | Dec 2023 |
|
Bank of New York Mellon | 57k | $369k | -19% | Dec 2023 |
|
Charles Schwab Investment Management | 55k | $358k | 0% | Dec 2023 |
|
Exchange Traded Concepts | 47k | $316k | 119% | Mar 2024 |
|
Baker Bros. Advisors | 45k | $290k | 0% | Dec 2023 |
|
GSA Capital Partners | 41k | $266k | 100% | Dec 2023 |
|
Barclays | 33k | $212k | 823% | Dec 2023 |
|
Alta Wealth Advisors | 30k | $194k | 100% | Dec 2023 |
|
Bank of America Corporation | 29k | $188k | 112% | Dec 2023 |
|
Rhumbline Advisers | 26k | $167k | -2% | Dec 2023 |
|
CornerCap Investment Counsel | 26k | $167k | 0% | Dec 2023 |
|
UBS Group | 23k | $151k | 124% | Dec 2023 |
|
Goldman Sachs Group | 14k | $92k | -11% | Dec 2023 |
|
Hsbc Holdings | 14k | $91k | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 13k | $85k | -37% | Dec 2023 |
|
Jane Street | 13k | $83k | 100% | Dec 2023 |
|
Fiduciary Trust Company | 11k | $70k | 0% | Dec 2023 |
|
American International | 10k | $65k | 0% | Dec 2023 |
|
Alliancebernstein | 10k | $65k | -7% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 10k | $64k | 0% | Dec 2023 |
|
Lazard Asset Management | 9.0k | $57k | 100% | Dec 2023 |
|
Royal Bank of Canada | 6.5k | $42k | 5% | Dec 2023 |
|
Wells Fargo & Company | 5.3k | $34k | 30% | Dec 2023 |
|
NISA Investment Advisors | 5.0k | $32k | 788% | Dec 2023 |
|
Citigroup | 2.9k | $19k | 438% | Dec 2023 |
|
Amalgamated Bank | 2.9k | $19k | -7% | Dec 2023 |
|
Legal & General Group | 2.0k | $13k | 0% | Dec 2023 |
|
New York State Common Retirement Fund | 1.9k | $12k | -2% | Dec 2023 |
|
Summit Investment Advisors | 1.5k | $9.9k | 0% | Dec 2023 |
|
Sunbelt Securities | 1.5k | $10k | 0% | Mar 2024 |
|
Washington Trust Company | 1.5k | $9.7k | 0% | Dec 2023 |
|
Capital Analysts | 547.00 | $4.0k | 0% | Dec 2023 |
|
VisionPoint Advisory Group | 210.00 | $1.4k | 0% | Dec 2023 |
|
TFC Financial Management | 123.00 | $794.001900 | 0% | Dec 2023 |
|
Russell Investments | 100.00 | $645.000000 | 100% | Dec 2023 |
|
Capital Advisors | 7.00 | $0 | 100% | Mar 2024 |
|
Zurcher Kantonalbank | 2.00 | $13.000000 | -100% | Dec 2023 |
|
CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Foghorn Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Deerfield Management Company | Sep 2023 | 778k | $3.9M |
GW & Wade | Sep 2023 | 108k | $539k |
Ikarian Capital | Sep 2023 | 15k | $77k |
MetLife Investment Advisors | Sep 2023 | 11k | $57k |
Metropolitan Life Insurance Company | Sep 2023 | 1.3k | $6.5k |
China Universal Asset Management | Sep 2023 | 1.1k | $5.0k |
Advisor Group Holdings | Sep 2023 | 300.00 | $1.5k |
Daiwa Securities Group | Sep 2023 | 168.00 | $1.0k |